Who can benefit from the NFI services?
Why as the help of Nord France Invest?
What type of project can support you in?
Do you have an expansion project?
Leave us your contact details and we’ll get back to you by e-mail.
Published on 16.07.2024 
“I think that we have everything we need to succeed in Hauts-de-France. “
Samuel Lecerf, Sr Site Director of West Pharmaceutical Services Le Nouvion
Established in Hauts-de-France since 1974, West Pharmaceutical Services has grown steadily to become a strategic plant for the Group.
What key success factors has the American giant found in the region?
“Le Nouvion is a key site in West Pharmaceutical Services’ global strategy. “
Samuel Lecerf, Sr Site Director of West Pharmaceutical Services Le Nouvion
📥 Download the full interview with de Samuel Lecerf
Founded in 1974, the Axon plant was acquired by the American company West Pharmaceutical Services in 1995.
Specializing in the manufacture of elastomer components for injectable solutions (stoppers, plungers and needle guards), it represents a strategic area of expertise for the Group.
Using state-of-the-art technology, the site exports its products to pharmaceutical and biotech industries worldwide.
To meet the needs of its customers, the West Group committed in 2023 to investing over $350 million worldwide over 5 years.
The Nouvion site will benefit from a $60 million program, which will allow for:
By boosting its modernization, these strategic investments will strengthen the site’s long-term viability and pave the way for its future development, serving not only its customers but also the healthcare sector in the Hauts-de-France region.
A long-standing stakeholder in the Thiérache region, the West Pharmaceutical Services site in Le Nouvion is celebrating its 50th anniversary in 2024.
With 750 employees, it is the largest private employer in the Aisne region.
The Group’s societal actions in the regions take the form of various partnerships with:
In 2023, the Group was also involved in the reflections on the healthcare component of France 2030 and took part in promoting the region’s industrial and research ecosystem, thereby making a significant contribution to strengthening France’s industrial sovereignty.
Every 3 years, Nord France Invest organizes an awards ceremony to highlight international companies that have made major investments in the region.
West Pharmaceutical Services won the 5th Industrial Investment Trophy. This award recognizes outstanding investment in a company’s production capacity.
It was awarded to the Group for its $60 million investment in 2023, a strong signal of the importance of the Le Nouvion site in its global strategy to ensure the plant’s long-term viability and productivity.
“Receiving this trophy in the year of our 50th anniversary in the region is a great source of pride for the whole team because they are the ones who work to develop the site. “
Samuel Lecerf
Horiba: groundbreaking innovation in the Hauts-de-France region
Octopus Energy accelerates its expansion from its base in the Hauts-de-France region
Agrati: from industrial recovery to lasting success in Hauts-de-France
Agristo invests in Escaudœuvres to strengthen its production in Europe
SQWAD is reinventing outsourced customer relationship managment
TMMF, Toyota’s “Made in France”
